Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tianjin Pharmaceutical Da Ren Tang Group Corp. Ltd. has appointed Ms. Wang Lei as the new Chairman of the Board and Mr. Xing Jianhua as a Director. These leadership changes were decided at the company’s 9th Board meeting for the fiscal year 2024, reflecting the company’s strategic direction and governance.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.